289 related articles for article (PubMed ID: 19995919)
21. Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences.
Xu Q; McShan K; Liang FT
Mol Microbiol; 2008 Jul; 69(1):15-29. PubMed ID: 18452586
[TBL] [Abstract][Full Text] [Related]
22. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.
Embers ME; Barthold SW; Borda JT; Bowers L; Doyle L; Hodzic E; Jacobs MB; Hasenkampf NR; Martin DS; Narasimhan S; Phillippi-Falkenstein KM; Purcell JE; Ratterree MS; Philipp MT
PLoS One; 2012; 7(1):e29914. PubMed ID: 22253822
[TBL] [Abstract][Full Text] [Related]
23. Comparison of in vitro activities of tigecycline, doxycycline, and tetracycline against the spirochete Borrelia burgdorferi.
Ates L; Hanssen-Hübner C; Norris DE; Richter D; Kraiczy P; Hunfeld KP
Ticks Tick Borne Dis; 2010 Mar; 1(1):30-4. PubMed ID: 21771509
[TBL] [Abstract][Full Text] [Related]
24. Lyme disease spirochete, Borrelia burgdorferi endemic at epicenter in Rondeau Provincial Park, Ontario.
Morshed MG; Scott JD; Fernando K; Mann RB; Durden LA
J Med Entomol; 2003 Jan; 40(1):91-4. PubMed ID: 12597659
[TBL] [Abstract][Full Text] [Related]
25. Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice.
Salo J; Jaatinen A; Söderström M; Viljanen MK; Hytönen J
PLoS One; 2015; 10(3):e0121512. PubMed ID: 25816291
[TBL] [Abstract][Full Text] [Related]
26. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
Das S; Barthold SW; Giles SS; Montgomery RR; Telford SR; Fikrig E
J Clin Invest; 1997 Mar; 99(5):987-95. PubMed ID: 9062357
[TBL] [Abstract][Full Text] [Related]
27. Immunization with a recombinant subunit OspA vaccine markedly impacts the rate of newly acquired Borrelia burgdorferi infections in client-owned dogs living in a coastal community in Maine, USA.
Eschner AK; Mugnai K
Parasit Vectors; 2015 Feb; 8():92. PubMed ID: 25890386
[TBL] [Abstract][Full Text] [Related]
28. OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks.
Tsao J; Barbour AG; Luke CJ; Fikrig E; Fish D
Vector Borne Zoonotic Dis; 2001; 1(1):65-74. PubMed ID: 12653137
[TBL] [Abstract][Full Text] [Related]
29. Distribution of clinically relevant Borrelia genospecies in ticks assessed by a novel, single-run, real-time PCR.
Rauter C; Oehme R; Diterich I; Engele M; Hartung T
J Clin Microbiol; 2002 Jan; 40(1):36-43. PubMed ID: 11773090
[TBL] [Abstract][Full Text] [Related]
30. Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development.
Izac JR; Oliver LD; Earnhart CG; Marconi RT
Vaccine; 2017 May; 35(24):3178-3185. PubMed ID: 28479174
[TBL] [Abstract][Full Text] [Related]
31. In vivo activities of ceftriaxone and vancomycin against Borrelia spp. in the mouse brain and other sites.
Kazragis RJ; Dever LL; Jorgensen JH; Barbour AG
Antimicrob Agents Chemother; 1996 Nov; 40(11):2632-6. PubMed ID: 8913478
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a genotyping method based on the ospA gene to detect Borrelia burgdorferi sensu lato in multiple samples of lyme borreliosis patients.
Floris R; Menardi G; Bressan R; Trevisan G; Ortenzio S; Rorai E; Cinco M
New Microbiol; 2007 Oct; 30(4):399-410. PubMed ID: 18080675
[TBL] [Abstract][Full Text] [Related]
33. In vitro activity of tigecycline against multiple strains of Borrelia burgdorferi.
Yang X; Nguyen A; Qiu D; Luft BJ
J Antimicrob Chemother; 2009 Apr; 63(4):709-12. PubMed ID: 19182236
[TBL] [Abstract][Full Text] [Related]
34. [Exploratory study on natural focus and its causative agent of genotype of Lyme disease by polymerase chain reaction in the forest areas of Beijing].
Li J; Cao W; Zhang X; Wu X; Zhang P; Zhao Q; Yang H; Dong Z; Cai S
Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Jun; 23(3):209-12. PubMed ID: 12411092
[TBL] [Abstract][Full Text] [Related]
35. Changes in temporal and spatial patterns of outer surface lipoprotein expression generate population heterogeneity and antigenic diversity in the Lyme disease spirochete, Borrelia burgdorferi.
Hefty PS; Jolliff SE; Caimano MJ; Wikel SK; Akins DR
Infect Immun; 2002 Jul; 70(7):3468-78. PubMed ID: 12065486
[TBL] [Abstract][Full Text] [Related]
36. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
de Silva AM; Telford SR; Brunet LR; Barthold SW; Fikrig E
J Exp Med; 1996 Jan; 183(1):271-5. PubMed ID: 8551231
[TBL] [Abstract][Full Text] [Related]
37. An OspA-based genospecies identification of Lyme disease spirochetes (Borrelia burgdorferi) isolated in Taiwan.
Shih CM; Chao LL
Am J Trop Med Hyg; 2002 May; 66(5):611-5. PubMed ID: 12201600
[TBL] [Abstract][Full Text] [Related]
38. Borrelia burgdorferi in small mammal reservoirs in Kentucky, a traditionally non-endemic state for Lyme disease.
Buchholz MJ; Davis C; Rowland NS; Dick CW
Parasitol Res; 2018 Apr; 117(4):1159-1167. PubMed ID: 29417273
[TBL] [Abstract][Full Text] [Related]
39. Two regulatory elements required for enhancing ospA expression in Borrelia burgdorferi grown in vitro but repressing its expression during mammalian infection.
Xu Q; McShan K; Liang FT
Microbiology (Reading); 2010 Jul; 156(Pt 7):2194-2204. PubMed ID: 20395273
[TBL] [Abstract][Full Text] [Related]
40. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs.
Scheckelhoff MR; Telford SR; Hu LT
Vaccine; 2006 Mar; 24(11):1949-57. PubMed ID: 16300863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
